Fintel reports that on January 21, 2025, RBC Capital downgraded their outlook for CF Industries Holdings (NYSE:CF) from ...

RBC Capital analyst Richard Chamberlain reiterated a Buy rating on Zalando (0QXN – Research Report) today. The company’s shares closed ...

In a report released today, Piral Dadhania from RBC Capital maintained a Buy rating on adidas AG (0OLD – Research Report), with a price target ...

Each year, RBC supports thousands of students from different educational backgrounds in exploring various career paths within ...

RBC Capital Markets updated its outlook on Compagnie Financiere Richemont SA (JO:CFRJ) (CFR:SW) (OTC: CFRUY), increasing the ...

However, its 2025 costs and capital expenditure guidance exceeded analyst expectations as well as its own previous guidance. For full-year 2025, Hochschild expects capital expenditure between $197 ...

Rivian (RIVN), and Lucid (LCID) are seeing declines after President Trump eliminated the Biden administration's EV mandate ...

Shares in Adidas climbed after the company beat its own profit expectations amid fierce competition in the sector and as its biggest rival, Nike, continues to pursue a brand revamp strategy.

SAGE Therapeutics Inc (SAGE) stock saw a modest uptick, ending the day at $7.08 which represents a slight increase of $0.11 or 1.58% from the prior close of $6.97. The stock opened at $7.02 and ...

GE Vernova's shares hit a new intraday high of over $407 on Tuesday, bolstered by investor confidence despite recent political developments. RBC Capital analysts ...

The analyst at RBC Capital expressed optimism about Health Catalyst (NASDAQ:HCAT)'s bookings outlook for 2025, which anticipates around 40 net new clients compared to 21 in 2024. However ...

Equity markets (^DJI, ^IXIC, ^GSPC) are roaring to go in their first trading session under the second Trump administration. Seana Smith and Brad Smith cover the market reactions to President Trump's ...